Neuroprotection and stroke: time for a compromise (Q36922560)

17 August 2017

1 reference

title

Neuroprotection and stroke: time for a compromise (English)

1 reference

17 August 2017

Carine Ali

2

0 references

Denis Vivien

object named as

Denis Vivien

series ordinal

4

0 references

author name string

Alan R Young

series ordinal

1

1 reference

PubMed ID

17727635

17 August 2017

Arnaud Duretête

series ordinal

3

1 reference

PubMed ID

17727635

17 August 2017

language of work or name

English

0 references

publication date

28 August 2007

1 reference

Journal of Neurochemistry

17 August 2017

1 reference

17 August 2017

103

1 reference

17 August 2017

4

1 reference

17 August 2017

1302-1309

1 reference

Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Cerebral ischemia: from animal studies to clinical practice. Should the methods be reviewed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Neutralizing the neurotoxic effects of exogenous and endogenous tPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Equivocal roles of tissue-type plasminogen activator in stroke-induced injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

MR perfusion and diffusion in acute ischemic stroke: human gray and white matter have different thresholds for infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Rodent models of focal stroke: size, mechanism, and purpose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Bench to bedside: the quest for quality in experimental stroke research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Pathobiology of ischaemic stroke: an integrated view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Is tissue-type plasminogen activator a neuromodulator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Therapeutic strategies for the treatment of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Quality improvement in acute stroke: the New York State Stroke Center Designation Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Translating animal research into clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Is white matter involved in patients entered into typical trials of neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Experimental models for the investigation of brain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Lost in translation: taking neuroprotection from animal models to clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

The neurotoxicity of tissue plasminogen activator?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Experimental thromboembolic stroke in cynomolgus monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Development of thrombolytic therapy for stroke: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Advances in ischemic stroke treatment: neuroprotective and combination therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

NXY-059 for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Tissue-type plasminogen activator rescues neurones from serum deprivation-induced apoptosis through a mechanism independent of its proteolytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

1,026 experimental treatments in acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Comparison of treatment effects between animal experiments and clinical trials: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Toward a multimodal neuroprotective treatment of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Human experimentation: no accurate, quantitative data?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Experimental treatments for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Better late than never?: the story of arterial recanalization in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

Recanalization after intravenous thrombolysis: does a recanalization time window exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

A mouse model of embolic focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04866.X

10.1111/J.1471-4159.2007.04866.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17727635